Analyst Reco. Nephros, Inc.

Equities

NEPH

US6406714005

Market Closed - Nasdaq Other stock markets 01:31:57 2024-06-04 pm EDT			5-day change	1st Jan Change
2.17 ^USD	-0.46%		-0.91%	-37.28%

May. 09	Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Transcript : Nephros, Inc., Q1 2024 Earnings Call, May 09, 2024

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

B. Riley Securities Lowers Nephros' Price Target to $4.25 from $5.25 Ahead of Q3 Results, Lowers Estimates; Maintains Buy Rating	22-10-19	MT
Benchmark Capital Downgrades Nephros to Hold From Speculative Buy	22-05-09	MT
B. Riley Lowers Nephros' Price Target to $5.25 from $8 After Lower-than-Expected Q1 Revenue, Keeps Buy Rating	22-05-05	MT
B. Riley Lowers Nephros' Price Target to $8 from $11.25, Lowers 2022 Estimates to Align with Management's Guidance; Maintains Buy Rating	22-02-16	MT
NEPHROS : B. Riley Starts Nephros at Buy With $12.50 Price Target	21-01-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer